Tirzepatide Demonstrates Reduction in Sleep Apnea-Relate Events
Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year.
Eli Lilly and Company will submit results of the study to support tirzepatide (Zepbound) for treatment of obstructive sleep apnea later this year.
This paper, part of the Cochrane Rapid Review Methods Group series, offers guidance on determining when to conduct a rapid review (RR) instead of a…
The Agency for Healthcare Research and Quality (AHRQ) Making Healthcare Safer (MHS) reports consolidate information for healthcare providers, health system administrators, researchers, and government agencies…
Nature – Lawmakers interrogated Peter Daszak over his ties to China and whether his organisation, EcoHealth Alliance, has been a good steward of taxpayer dollars.
March 2024 R. Henry Olaisen, Ph.D., M.P.H., P.M.P., and Marc Roemer, M.S. Prior to the COVID-19 pandemic, 95 percent of all emergency department (ED) visits…
Panelists compare the currently available RSV vaccines for adults, considering their target populations, dosing, and administration to prevent RSV infection.
AHRQ advances excellence in healthcare by producing evidence to make healthcare safer, higher quality, more accessible, equitable, and affordable.
Use of digital healthcare technologies – for clinicians and patients – is growing. To ensure these solutions benefit all patient groups, creators and users must be…
This webcast discussed Indiana Hospital Association’s experiences using the Surveys on Patient Safety Culture® (SOPS®) Hospital Survey and Workplace Safety Item Set. They shared their…
Telemedicine use remains substantially higher than it was before the COVID-19 pandemic, although it has fallen from pandemic highs. To inform the ongoing debate about…